Neurology Clinical Trials Market Size, Share Report, Analysis, Trends, Growth, 2032

Neurology Clinical Trials Market

Neurology Clinical Trials Market- By Phase (Phase I, Phase II, Phase III, and Phase IV), By Study Design (Interventional, Observational, and Expanded Access), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032

Category: Healthcare Report Format : PDF Pages: 158 Report Code: ZMR-6777 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 21.51 Billion USD 32.80 Billion 4.8% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodulogy
  • Chapter 2. Executive Summary
    • 2.1. Neurulogy Clinical Trials Market, 2018–2028(USD Billion)
    • 2.2. Neurulogy Clinical Trials Market: Snapshot
  • Chapter 3. Global Neurulogy Clinical Trials Market– Industry Analysis
    • 3.1. Neurulogy Clinical Trials Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Escalating requirements for effectively treating neurulogical disorders such as Alzheimer and Parkinson disease will translate into humungous growth of neurulogy clinical trials market.
      • 3.2.2. Technulogical innovations in biotech & pharma sectors can increase proficiency of neurulogy clinical trials along with enhance patient engagement, thereby pushing business trends.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Phase
      • 3.4.2. Market attractiveness analysis By Study Design
  • Chapter 4. Global Neurulogy Clinical Trials Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Neurulogy Clinical Trials Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Neurulogy Clinical Trials Market– Phase Analysis
    • 5.1. Global Neurulogy Clinical Trials Marketoverview: By Phase
      • 5.1.1. Global Neurulogy Clinical Trials Marketshare, By Phase, 2020 and 2028
    • 5.2. Phase IV
      • 5.2.1. Global Neurulogy Clinical Trials Marketby Phase IV, 2018–2028(USD Billion)
    • 5.3. Phase I
      • 5.3.1. Global Neurulogy Clinical Trials Marketby Phase I, 2018–2028(USD Billion)
    • 5.4. Phase II
      • 5.4.1. Global Neurulogy Clinical Trials Marketby Phase II, 2018–2028(USD Billion)
    • 5.5. Phase III
      • 5.5.1. Global Neurulogy Clinical Trials Marketby Phase III, 2018–2028(USD Billion)
  • Chapter 6. Global Neurulogy Clinical Trials Marketoverview: By Study Design
    • 6.1.1. Global Neurulogy Clinical Trials Market share, By Study Design, 2020 and 2028
    • 6.2. Interventional
      • 6.2.1. Global Neurulogy Clinical Trials Marketby Interventional, 2018–2028(USD Billion)
    • 6.3. Observational
      • 6.3.1. Global Neurulogy Clinical Trials Marketby Observational, 2018–2028(USD Billion)
    • 6.4. Expanded Access
      • 6.4.1. Global Neurulogy Clinical Trials Marketby Expanded Access, 2018–2028(USD Billion)
  • Chapter 7. Company Profiles
    • 7.1. Novartis AG
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product Portfulio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Labcorp Drug Development
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product Portfulio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Charles River Laboratories
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product Portfulio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Development
    • 7.4. Medpace Huldings, Inc.
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product Portfulio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Development
    • 7.5. Icon Plc
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product Portfulio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Syneos Health
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product Portfulio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. GlaxoSmithKline Plc
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product Portfulio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. Aurora Healthcare
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product Portfulio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development
    • 7.9. Biogen Inc.
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Product Portfulio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Development
    • 7.10. IQVIA
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Product Portfulio
      • 7.10.4. Business Strategy
      • 7.10.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global Clinical Trial Supply and Logistics Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Clinical Trial Supply and Logistics Marketattractiveness, By Phase
6. Global Clinical Trial Supply and Logistics Marketattractiveness by Study Design 
7. Global Clinical Trial Supply and Logistics Marketshare by Phase ,2020 and 2028 (USD Billion)
8. Global Clinical Trial Supply and Logistics Marketby Phase IV, 2018–2028(USD Billion)
9. Global Clinical Trial Supply and Logistics Marketby Phase I, 2018–2028(USD Billion)
10. Global Clinical Trial Supply and Logistics Marketby Phase II, 2018–2028(USD Billion)
11. Global Clinical Trial Supply and Logistics Marketby Phase III, 2018–2028(USD Billion)
12. Global Clinical Trial Supply and Logistics Marketshare by Study Design ,2020 and 2028 (USD Billion)
13. Global Clinical Trial Supply and Logistics Marketby Interventional, 2018–2028(USD Billion)
14. Global Clinical Trial Supply and Logistics Marketby Observational, 2018–2028(USD Billion)
15. Global Clinical Trial Supply and Logistics Marketby Expanded Access, 2018–2028(USD Billion)
16. Global Clinical Trial Supply and Logistics Marketshare, by Region, 2020 and 2028
17. North America Clinical Trial Supply and Logistics Market, 2018–2028(USD Billion)
18. Europe Clinical Trial Supply and Logistics Market, 2018–2028(USD Billion)
19. Asia Pacific Clinical Trial Supply and Logistics Market, 2018–2028(USD Billion)
20. Latin America Clinical Trial Supply and Logistics Market, 2018–2028(USD Billion)
21. The Middle East and Africa Clinical Trial Supply and Logistics Market, 2018–2028(USD Billion)
 


Table Of Tables

List of Tables

1. Global Clinical Trial Supply and Logistics Market: snapshot
2. Drivers of the Clinical Trial Supply and Logistics Market: impact analysis
3. North America Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
4. North America Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)
5. The U.S. Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
6. The U.S. Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)
7. Rest of North America Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
8. Rest of North America Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)
9. Europe Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
10. Europe Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)
11. UK Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
12. UK Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)
13. France Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
14. France Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)
15. Germany Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
16. Germany Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)
17. Rest of Europe Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
18. Rest of Europe Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)
19. Asia Pacific Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
20. Asia Pacific Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)
21. China Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
22. China Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)
23. Japan Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
24. Japan Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)
25. India Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
26. India Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)
27. Rest of Asia Pacific Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
28. Rest of North America Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)
29. Latin America Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
30. Latin America Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)
31. Brazil Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
32. Brazil Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)
33. Rest of Latin America Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
34. Rest of Latin America Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)
35. The Middle East and Africa Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
36. The Middle East and Africa Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)
37. Saudi Arabia Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
38. Saudi Arabia Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)
39. South Africa Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
40. South Africa Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)
41. Rest of the Middle East & Africa Neurology Clinical Trials Marketrevenue, By Phase  ,2018–2028(USD Billion)
42. Rest of the Middle East & Africa Neurology Clinical Trials Marketrevenue, By Study Design ,2018–2028(USD Billion)

 

Methodology

FrequentlyAsked Questions

Neurology clinical trials are research studies focused on brain and nervous system disorders. They evaluate the safety and effectiveness of new treatments
The global Neurology Clinical Trials market is expected to be driven by the rising prevalence of neurological disorders and unmet treatment needs. Advancements in biomarkers, imaging, and targeted therapies support increased trial activity.
According to study, the global Neurology Clinical Trials market size was worth around USD 21.51 Billion in 2023 and is predicted to grow to around USD 32.80 Billion By 2032.
The global Neurology Clinical Trials market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 4.8% during the forecast period from 2024-2032.
The global Neurology Clinical Trials industry is projected to be challenged by Challenges include long timelines and complex patient recruitment.
The Opportunities include rising neurological disorders, CNS drug pipelines, biomarker-driven trials, and R&D investment will offer significant growth opportunities in the Neurology Clinical Trials market.
Adaptive trial designs; digital biomarkers and remote monitoring; focus on neurodegenerative diseases are the emerging trends and innovations impacting the Neurology Clinical Trials market.
The global Neurology Clinical Trials market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global Neurology Clinical Trials market are; Novartis AG, Labcorp Drug Development, Charles River Laboratories, Medpace Holdings, Inc., Icon Plc, Syneos Health, GlaxoSmithKline Plc, Aurora Healthcare, Biogen Inc., and IQVIA. and others.
The report explores crucial aspects of the Neurology Clinical Trials market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
  • zion payment modes

List of Contents

Market InsightsIndustry Perspective:OutlookGrowth DriversReport ScopeMarket:​Regional LandscapeMarket:​​Competitive LandscapeThe global Market is segmented as follows:By PhaseBy Study DesignBy Region

HappyClients